FRIDAY, Oct. 20, 2017 -- Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests.
Hepatitis B virus attacks the liver and can cause cirrhosis and liver cancer. Previous research suggests daily low-dose aspirin therapy may prevent cancer, but there is little clinical evidence on whether regular aspirin use can prevent liver cancer in people with hepatitis B.
FRIDAY, Oct. 20, 2017 -- Allergies and asthma can make exercise more challenging. But if your condition is well managed and you take a few precautions, you should be able to work out without worry.
Know your allergy or asthma triggers and exercise around them. For instance, when the pollen count is high, exercise indoors with windows and doors closed. When you do exercise outside, avoid high-allergen areas like grassy fields, parks and heavily trafficked roads.
FRIDAY, Oct. 20, 2017 -- Drug overdose death rates in rural areas of the United States are now higher than in cities, a trend that worries federal health officials.
In 2015, drug overdose was the leading cause of injury-related death in the United States -- with 52,000 fatalities attributed to opioid painkillers, heroin and other potentially deadly drugs, researchers said in a new report.
FRIDAY, Oct. 20, 2017 -- A combination of yoga and aerobic exercise may benefit people with heart disease, according to a new study.
"Combined Indian yoga and aerobic exercise reduce mental, physical and vascular stress and can lead to decreased cardiovascular mortality and morbidity," said study authors Sonal Tanwar and Dr. Naresh Sen, from Hridaya Ganesha Sunil Memorial Superspeciality Hospital in Jaipur, India.
FRIDAY, Oct. 20, 2017 -- Depending on the cancer, between one and 10 genetic mutations are needed to trigger the development of tumors, a new study reports.
"We have addressed a longstanding question in cancer research that has been debated since the 1950s: How many mutations are needed for a normal cell to turn into a cancer cell?" said study author Peter Campbell, with the Wellcome Trust Sanger Institute in Cambridge, England.